Centre Hospitalier de Lens has awarded a €10.24M cardiology and vascular medical devices framework to multiple suppliers across nine lots

Centre Hospitalier de Lens, a body governed by public law operating in the health sector, on behalf of the hospital centres of Lens and Béthune, has awarded a framework agreement for the supply of cardiology and vascular medical devices for 2026 (FOURNITURE DE DMS DE CARDIOLOGIE ET VASCULAIRE 2026 POUR LES CENTRES HOSPITALIERS DE LENS ET DE BETHUNE) to multiple suppliers. The maximum framework value in this notice is €10,243,533.00, covering cardiac stimulation devices across thirteen lots, with each lot awarded separately and services paid at unit prices. The contract was awarded following an open procedure under the standard regime, governed by EU Directive 2014/24/EU. This is a relaunch of procedure 2025-150.

Introduction

Centre Hospitalier de Lens, a body governed by public law operating in the health sector, has conducted an open procedure for the supply of cardiology and vascular medical devices for 2026 for the hospital centres of Lens and Béthune. The framework agreement will be executed by issuing purchase orders. Each lot is awarded separately. Services are paid at unit prices. The thresholds are expressed in quantity within the consultation documents. The procurement is a relaunch of procedure 2025-150. The framework covers thirteen lots: Catheter for endocoronary imaging, Vessel dilator 08F to 24F, Coronary endoprosthesis with active ingredient, Covered coronary endoprosthesis, Coronary dilatation probe with active principle, Coronary dilatation probe with active principle (depot), High-pressure valvuloplasty dilatation probe, Percutaneous clip system for mitral valve, Aortic valve by percutaneous implantation auto-expandable, Aortic valve by percutaneous implantation expandable on balloon, Microcatheter for arterial embolisation, Peripheral dilatation probe with active ingredient release, and Peripheral dilatation probe with active ingredient release (depot).

The procurement is not financed with EU funds but is covered by the Government Procurement Agreement (GPA). The evaluation criteria are product quality (60%), threshold of complementary commercial conditions (2%) and price of services and complementary commercial conditions (38%). Each lot may be renewed once under the conditions of the specifications. The framework agreement operates without reopening of competition. Multiple tenders were received per lot, and winners include Abbott Medical France SAS, iVascular, Cordis France SAS, B. Braun Medical, Becton Dickinson France, Medtronic, Edwards Lifesciences SAS, and Terumo France SAS. Four lots (LOT-0002, LOT-0004, LOT-0005, LOT-0012) resulted in no winner being chosen and the competitions were closed (reason: Other).

Why This Contract Matters

This framework ensures that the hospital centres of Lens and Béthune have access to a broad range of cardiology and vascular medical devices from multiple suppliers.

This contract matters because it:

• Supports Healthcare Services: Provides cardiology and vascular medical devices
• Significant Value: €10,243,533.00 maximum framework value in this notice
• Thirteen Lots: Each lot awarded separately
• Renewal Option: Each lot may be renewed once
• Quality Focus: 60% product quality, 38% price, 2% complementary commercial conditions
• Mixed Outcome: Nine lots awarded; four lots closed without a winner
• Strong Competition: Up to 9 tenders received for some lots

Contract Timeline

• Contract concluded: 15-16 September 2026 (various)
• Maximum renewals: 1 per lot
• Notice published: 18 September 2026 (OJ S 181/2026)
• Notice dispatch date: 17 September 2026
• Previous notice: 217335-2026

Contract Overview

Centre Hospitalier de Lens conducted an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Key features include:

• Thirteen lots (each awarded separately)
• Maximum framework value in this notice: €10,243,533.00
• Maximum renewals: 1 per lot
• Framework type: Framework agreement, without reopening of competition
• Evaluation: Product quality (60%), Threshold of complementary commercial conditions (2%), Price (38%)
• Winners: Abbott Medical France SAS; iVascular; Cordis France SAS; B. Braun Medical; Becton Dickinson France; Medtronic; Edwards Lifesciences SAS; Terumo France SAS
• Subcontracting: No
• No EU funding
• Covered by GPA: Yes

Key Contract Details

• Main classification: 33182200 Cardiac stimulation devices
• Additional classification: 33182200 Cardiac stimulation devices
• Place of performance: Lens and Béthune, Pas-de-Calais, France (NUTS: FRE12)
• Procedure identifier: ca7e7652-a933-4e97-9aa3-a1095b2c7eeb
• Internal identifier: 2026-047
• Type of procedure: Open
• Accelerated procedure: No
• Legal basis: Directive 2014/24/EU
• Review body: Tribunal administratif de Lille
• Review deadline: Référé pré-contractuel (before contract signature); Référé contractuel (per R. 551-7 CJA); Recours pour excès de pouvoir (within 2 months); Recours de pleine juridiction (within 2 months of publication of contract conclusion)

Lot Structure

LOT-0001 – Catheter for Endocoronary Imaging

• Internal identifier: 01
• Winner: Abbott Medical France SAS (€225,000.00)
• Tenders received: 2
• Contract concluded: 16 September 2026
• Contract identifier: 260202

LOT-0002 – Vessel Dilator 08F to 24F

• Internal identifier: 02
• Result: No winner was chosen and the competition is closed (reason: Other)
• Tenders received: 1

LOT-0003 – Coronary Endoprosthesis with Active Ingredient

• Internal identifier: 03
• Winners: Abbott Medical France SAS (€775,425.00); iVascular (€668,167.00)
• Tenders received: 9 (1 from an SME)
• Contract concluded: 16 September 2026
• Contract identifiers: 260203; 260204

LOT-0004 – Covered Coronary Endoprosthesis

• Internal identifier: 04
• Result: No winner was chosen and the competition is closed (reason: Other)
• Tenders received: 1

LOT-0005 – Coronary Dilatation Probe with Active Principle

• Internal identifier: 05
• Result: No winner was chosen and the competition is closed (reason: Other)
• Tenders received: 8

LOT-0006 – Coronary Dilatation Probe with Active Principle (Depot)

• Internal identifier: 06
• Winners: Cordis France SAS (€413,100.00); B. Braun Medical (€432,000.00)
• Tenders received: 6 (1 from an SME)
• Contract concluded: 16 September 2026
• Contract identifiers: 260206; 260205

LOT-0007 – High-Pressure Valvuloplasty Dilatation Probe

• Internal identifier: 07
• Winner: Becton Dickinson France (€16,800.00)
• Tenders received: 1
• Contract concluded: 15 September 2026
• Contract identifier: 260207

LOT-0008 – Percutaneous Clip System for Mitral Valve

• Internal identifier: 08
• Winner: Abbott Medical France SAS (€879,167.00)
• Tenders received: 8 (2 electronic)
• Contract concluded: 16 September 2026
• Contract identifier: 260208

LOT-0009 – Aortic Valve by Percutaneous Implantation Auto-Expandable

• Internal identifier: 09
• Winner: Medtronic (€1,819,875.00)
• Tenders received: 2
• Contract concluded: 16 September 2026
• Contract identifier: 260209

LOT-0010 – Aortic Valve by Percutaneous Implantation Expandable on Balloon

• Internal identifier: 10
• Winner: Edwards Lifesciences SAS (€4,853,000.00)
• Tenders received: 1
• Contract concluded: 15 September 2026
• Contract identifier: 260110

LOT-0011 – Microcatheter for Arterial Embolisation

• Internal identifier: 11
• Winner: Terumo France SAS (€70,000.00)
• Tenders received: 4
• Contract concluded: 15 September 2026
• Contract identifier: 260211

LOT-0012 – Peripheral Dilatation Probe with Active Ingredient Release

• Internal identifier: 12
• Result: No winner was chosen and the competition is closed (reason: Other)
• Tenders received: 6 (1 from an SME)

LOT-0013 – Peripheral Dilatation Probe with Active Ingredient Release (Depot)

• Internal identifier: 13
• Winner: Medtronic (€91,000.00)
• Tenders received: 6 (1 from an SME)
• Contract concluded: 16 September 2026
• Contract identifier: 260212

Lot Summary Table

Lot	Title	Value (€)	Winner	Tenders
1	Catheter for Endocoronary Imaging	225,000.00	Abbott Medical France SAS	2
2	Vessel Dilator 08F to 24F	—	No winner chosen	1
3	Coronary Endoprosthesis with Active Ingredient	775,425.00 / 668,167.00	Abbott Medical France SAS; iVascular	9
4	Covered Coronary Endoprosthesis	—	No winner chosen	1
5	Coronary Dilatation Probe with Active Principle	—	No winner chosen	8
6	Coronary Dilatation Probe with Active Principle (Depot)	413,100.00 / 432,000.00	Cordis France SAS; B. Braun Medical	6
7	High-Pressure Valvuloplasty Dilatation Probe	16,800.00	Becton Dickinson France	1
8	Percutaneous Clip System for Mitral Valve	879,167.00	Abbott Medical France SAS	8
9	Aortic Valve by Percutaneous Implantation Auto-Expandable	1,819,875.00	Medtronic	2
10	Aortic Valve by Percutaneous Implantation Expandable on Balloon	4,853,000.00	Edwards Lifesciences SAS	1
11	Microcatheter for Arterial Embolisation	70,000.00	Terumo France SAS	4
12	Peripheral Dilatation Probe with Active Ingredient Release	—	No winner chosen	6
13	Peripheral Dilatation Probe with Active Ingredient Release (Depot)	91,000.00	Medtronic	6
Total		10,243,533.00 (max)

Scope of Supply

The framework covers the following medical devices:

• Catheter for Endocoronary Imaging: Catheter for endocoronary imaging
• Vessel Dilator: Vessel dilator 08F to 24F
• Coronary Endoprosthesis: Coronary endoprosthesis with active ingredient
• Covered Coronary Endoprosthesis: Covered coronary endoprosthesis
• Coronary Dilatation Probe: Coronary dilatation probe with active principle
• Valvuloplasty Probe: High-pressure valvuloplasty dilatation probe
• Mitral Valve Clip: Percutaneous clip system for mitral valve
• Aortic Valves: Aortic valve by percutaneous implantation (auto-expandable and expandable on balloon)
• Microcatheter: Microcatheter for arterial embolisation
• Peripheral Dilatation Probe: Peripheral dilatation probe with active ingredient release

Special Procurement Conditions

• Separate Award: Each lot is awarded separately
• Purchase Orders: The framework agreement will be executed by issuing purchase orders
• Unit Prices: Services are paid at unit prices
• Thresholds: Thresholds are expressed in quantity within the consultation documents
• Renewal: Each lot may be renewed once under the conditions of the specifications
• Framework Agreement: Framework agreement, without reopening of competition
• No Winner (Lots 2, 4, 5, 12): No winner was chosen and the competitions were closed (reason: Other)
• No Subcontracting: No subcontracting declared by winners

About the Contracting Authority

Centre Hospitalier de Lens is a body governed by public law operating in the health sector in France, procuring on behalf of the hospital centres of Lens and Béthune.

• Legal type: Body governed by public law
• Activity: Health
• Registration number: 66620
• Location: Lens, Pas-de-Calais, France (NUTS: FRE12)
• Address: 99 Route de La Bassée, 62307 Lens
• Contact point: DONIUS Bruno
• Email: correspondre@aws-france.com
• Telephone: 0321691234
• Internet address: https://www.ght-artois.fr/

About the Winning Suppliers

Abbott Medical France SAS – Large enterprise, Issy-Les-Moulineaux, France (NUTS: FR105); Winner of LOT-0001, LOT-0003 and LOT-0008

iVascular – SME, Cagnes-Sur-Mer, France (NUTS: FRL03); Winner of LOT-0003

Cordis France SAS – Large enterprise, Issy-Les-Moulineaux, France (NUTS: FR105); Winner of LOT-0006

B. Braun Medical – Large enterprise, Saint-Cloud, France (NUTS: FR105); Winner of LOT-0006

Becton Dickinson France – Large enterprise, Le Pont-De-Claix, France (NUTS: FRK24); Winner of LOT-0007

Medtronic – Large enterprise, Paris 14, France (NUTS: FR101); Winner of LOT-0009 and LOT-0013

Edwards Lifesciences SAS – Large enterprise, Guyancourt, France (NUTS: FR103); Winner of LOT-0010

Terumo France SAS – Large enterprise, Rueil-Malmaison, France (NUTS: FR105); Winner of LOT-0011

Evaluation Criteria

All awarded lots use the same evaluation criteria:

• Product Quality (60%): Packaging and labelling, technical value, performance based on tests or examinations of the products
• Threshold of Complementary Commercial Conditions (2%): Seuil des conditions commerciales complémentaires
• Price (38%): Price of services and complementary commercial conditions (see Annex 6)

Procurement Analysis

• Procedure: Open procedure under the standard regime, governed by EU Directive 2014/24/EU
• Competition: 1 to 9 tenders received per lot
• Subcontracting: No subcontracting declared
• No EU funding: The procurement was not financed with EU funds
• Framework agreement: Framework agreement, without reopening of competition
• No dynamic purchasing system used
• Accelerated procedure: No
• Review body: Tribunal administratif de Lille
• Call for competition terminated: Nine lots awarded; four lots closed without a winner

Additional Procurement Facts

• The contract is covered by the WTO's Government Procurement Agreement (GPA)
• No EU funds were used for this procurement
• The maximum framework value in this notice is €10,243,533.00
• The framework is divided into thirteen lots, each awarded separately
• Product quality (60%), threshold of complementary commercial conditions (2%) and price (38%) are the evaluation criteria
• 1 to 9 tenders were received per lot
• Winners include large enterprises and one SME
• No subcontracting was declared
• Each lot may be renewed once
• Lots 2, 4, 5 and 12 closed without a winner
• This is a relaunch of procedure 2025-150

Market & Industry Perspective

The French public sector cardiology and vascular medical devices market features a mix of large international manufacturers and specialised SMEs. Cardiology and vascular devices are essential for diagnostic and interventional procedures in hospital centres.

Key trends in this market include:

• Quality focus: 60% product quality, 38% price, 2% complementary commercial conditions
• Large providers: Dominance of large medical device manufacturers
• SME participation: One SME winner (iVascular)
• Multi-lot structure: Thirteen lots, each awarded separately
• Renewable contracts: Each lot may be renewed once
• Partial award: Nine lots awarded; four lots closed without a winner

Economic Significance

At €10,243,533.00 maximum framework value in this notice, this framework represents a significant investment in cardiology and vascular medical devices for the hospital centres of Lens and Béthune. The contract will:

• Support Healthcare Services: Provide cardiology and vascular medical devices
• Support Both Large Enterprises and SMEs: Winners include large enterprises and one SME
• Provide Stability: Each lot may be renewed once
• Ensure Supply Security: Multiple suppliers across thirteen lots
• Enable Clinical Excellence: Access to advanced cardiology and vascular devices
• Support Patient Care: Facilitate diagnostic and interventional procedures

Future Procurement Opportunities

With this framework now in place, future opportunities include:

• Re-tender: Expected after the framework period including renewals
• Lots 2, 4, 5 and 12: Potential re-tender following closure without a winner
• Related Supplies: Additional cardiology and vascular medical devices
• Subcontracting: Potential opportunities with framework winners
• Other Hospital Centres: Similar cardiology device procurement opportunities

Opportunities for Suppliers

While this contract is awarded, opportunities remain for medical device suppliers:

• Re-tender: Prepare for future procurement cycles
• Lots 2, 4, 5 and 12: Prepare for potential re-tender
• Subcontracting: Potential opportunities with framework winners
• Related Supplies: Other cardiology and vascular medical devices
• Other French Hospital Centres: Similar cardiology device procurements

What Businesses Should Watch

• Centre Hospitalier de Lens's future procurement notices
• Re-tender of Lots 2, 4, 5 and 12
• Other French hospital cardiology device tenders
• Cardiology and vascular device market trends
• Changes to French procurement regulations
• Renewal option decisions

FranceTenders.com Procurement Intelligence

This cardiology and vascular medical devices framework is a notable example of French public sector procurement. Several features stand out:

• Scale: €10.24M maximum framework value in this notice
• Quality focus: 60% product quality, 38% price, 2% commercial conditions
• Thirteen lots: Each awarded separately
• Multiple winners: Eight suppliers appointed across nine lots
• Partial award: Lots 2, 4, 5 and 12 closed without a winner
• Competition: 1 to 9 tenders per lot
• Relaunch: Relaunch of procedure 2025-150

For suppliers, this procurement highlights the importance of:

• Product quality: 60% product quality-based evaluation
• Competitive pricing: 38% price-based evaluation
• Commercial conditions: 2% complementary commercial conditions
• Cardiology and vascular expertise: Ability to supply specialised medical devices
• Public sector experience: Understanding of French hospital requirements
• Regulatory compliance: Compliance with medical device regulations

Supplier Takeaways

• Ensure high product quality – 60% of evaluation is product quality-based
• Offer competitive pricing – 38% of evaluation is price-based
• Demonstrate strong commercial conditions – 2% of evaluation
• Showcase cardiology and vascular medical device capability
• Develop public sector experience with French hospital centres
• Monitor Centre Hospitalier de Lens and French hospital procurement opportunities
• Prepare for potential re-tender of Lots 2, 4, 5 and 12

Key Takeaways

• Centre Hospitalier de Lens awarded a €10,243,533.00 cardiology and vascular medical devices framework on behalf of the hospital centres of Lens and Béthune
• Thirteen lots, each awarded separately: catheters, dilators, endoprostheses, dilatation probes, valve systems, microcatheters and peripheral probes
• Evaluation: Product quality (60%), Threshold of complementary commercial conditions (2%) and Price (38%)
• 1 to 9 tenders received per lot
• Nine lots awarded to eight suppliers; four lots closed without a winner
• Winners include Abbott Medical France SAS, iVascular, Cordis France SAS, B. Braun Medical, Becton Dickinson France, Medtronic, Edwards Lifesciences SAS and Terumo France SAS
• Winners include large enterprises and one SME
• No subcontracting declared
• No EU funding
• Covered by GPA: Yes
• Each lot may be renewed once
• This is a relaunch of procedure 2025-150

Conclusion

This cardiology and vascular medical devices framework ensures that the hospital centres of Lens and Béthune have access to a broad range of specialised medical devices from multiple suppliers. By awarding nine of the thirteen lots to eight suppliers, the Centre Hospitalier de Lens secures a diverse panel with the capability to deliver catheters, dilators, endoprostheses, dilatation probes, valve systems, microcatheters and peripheral probes.

The 60% product quality, 38% price and 2% complementary commercial conditions evaluation reflects the clinically driven nature of medical device procurement, where product quality is the primary differentiator among qualified suppliers. The multi-lot structure and the partial award outcome reflect the complexities of public procurement in specialised medical device markets.

For suppliers, this procurement highlights the importance of product quality, competitive pricing, commercial conditions, cardiology and vascular expertise, public sector experience, and regulatory compliance in winning French public sector medical device contracts. The closure of Lots 2, 4, 5 and 12 without a winner also signals potential re-tender opportunities in the future.

Frequently Asked Questions

Q: What is Centre Hospitalier de Lens?

Ans: A body governed by public law operating in the health sector in France, procuring on behalf of the hospital centres of Lens and Béthune.

Q: What is the value of the framework?

Ans: Maximum framework value in this notice €10,243,533.00.

Q: Who are the winners?

Ans: Abbott Medical France SAS (Lots 1, 3, 8); iVascular (Lot 3); Cordis France SAS (Lot 6); B. Braun Medical (Lot 6); Becton Dickinson France (Lot 7); Medtronic (Lots 9, 13); Edwards Lifesciences SAS (Lot 10); Terumo France SAS (Lot 11).

Q: What supplies are covered?

Ans: Cardiology and vascular medical devices across thirteen lots, including catheters, vessel dilators, coronary endoprostheses, dilatation probes, valve systems, microcatheters and peripheral probes.

Q: What were the evaluation criteria?

Ans: Product quality (60%), Threshold of complementary commercial conditions (2%) and Price (38%).

Q: How long is the contract?

Ans: Each lot may be renewed once under the conditions of the specifications.

Q: How many tenders were received?

Ans: Between 1 and 9 tenders per lot.

Q: Is this contract funded by the EU?

Ans: No, the procurement is not financed with EU funds.

Q: What is the review body?

Ans: Tribunal administratif de Lille.

Q: What is the lot structure?

Ans: Thirteen lots – LOT-0001 to LOT-0013, each awarded separately.

Q: Were all lots awarded?

Ans: No, Lots 2, 4, 5 and 12 resulted in no winner being chosen and the competitions were closed. The other nine lots were awarded.

Q: Is subcontracting allowed?

Ans: No subcontracting was declared by the winners.

Q: What is the relaunch reference?

Ans: This is a relaunch of procedure 2025-150 (new reference 2026-047).

Source: EU Official Journal, Contract Award Notice 643210-2026, OJ S 181/2026, published 18 September 2026.

```